LEXICON PHARMACEUTICALS INC's ticker is LXRX and the CUSIP is 528872302. A total of 125 filers reported holding LEXICON PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 3.94 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $2,993 | +2.3% | 1,500 | 0.0% | 0.00% | – |
| Q1 2020 | $2,925 | -53.0% | 1,500 | 0.0% | 0.00% | -100.0% |
| Q4 2019 | $6,225 | +37.9% | 1,500 | 0.0% | 0.00% | – |
| Q3 2019 | $4,515 | -52.1% | 1,500 | 0.0% | 0.00% | -100.0% |
| Q2 2019 | $9,435 | +13.1% | 1,500 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $8,340 | -16.3% | 1,500 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $9,960 | -37.8% | 1,500 | 0.0% | 0.00% | -50.0% |
| Q3 2018 | $16,005 | -11.1% | 1,500 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $18,000 | +40.0% | 1,500 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $12,855 | -13.3% | 1,500 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $14,820 | -19.6% | 1,500 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $18,435 | – | 1,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ulys, L.L.C. | 4,321,214 | $34,786,000 | 99.98% |
| Artal Group S.A. | 57,517,978 | $463,019,000 | 19.93% |
| MASTERS CAPITAL MANAGEMENT LLC | 1,129,708 | $9,094,000 | 0.30% |
| Rhenman & Partners Asset Management AB | 170,915 | $1,376,000 | 0.16% |
| Round Table Services, LLC | 21,611 | $174,000 | 0.14% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 35,714 | $287,000 | 0.10% |
| FALCON POINT CAPITAL, LLC | 37,039 | $298,000 | 0.10% |
| SABBY MANAGEMENT, LLC | 318,775 | $2,566,000 | 0.09% |
| WILLIAM HARRIS INVESTORS INC | 39,495 | $318,000 | 0.09% |
| HOWARD HUGHES MEDICAL INSTITUTE | 51,520 | $415,000 | 0.09% |